Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13,831,528
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
666,895
-
Shares change
-
-71,743
-
Total reported value, excl. options
-
$1,594,259
-
Value change
-
-$144,985
-
Number of buys
-
4
-
Number of sells
-
-5
-
Price
-
$2.39
Significant Holders of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) as of Q2 2023
20 filings reported holding COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share as of Q2 2023.
Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 666,895 shares
of 13,831,528 outstanding shares and own 4.82% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (271,445 shares), RENAISSANCE TECHNOLOGIES LLC (124,528 shares), BlackRock Inc. (74,063 shares), GEODE CAPITAL MANAGEMENT, LLC (69,534 shares), MORGAN STANLEY (44,453 shares), STATE STREET CORP (24,443 shares), Parallel Advisors, LLC (15,228 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (14,897 shares), NORTHERN TRUST CORP (12,207 shares), and BANK OF AMERICA CORP /DE/ (8,975 shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.